| |
| |
|
| Insider
Information: |
Monahan Joseph |
| Relationship: |
Chief Scientific Officer |
| City: |
Wayne |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
186,783 |
|
|
Indirect Shares
|
193 |
|
|
| Direct
Value |
$220,404 |
|
|
|
Indirect Value
|
$228 |
|
|
| Total
Shares |
186,976 |
|
|
| Total
Value |
$220,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Scientific Officer |
2024-03-02 |
186,783 |
2024-03-02 |
193 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-02 |
4 |
D |
$1.24 |
$4,378 |
D/D |
(3,531) |
186,783 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
190,314 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-01 |
4 |
D |
$1.24 |
$22,012 |
D/D |
(17,752) |
177,814 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,925 |
180,997 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-02-01 |
4 |
D |
$1.20 |
$3,100 |
D/D |
(2,583) |
134,641 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
137,224 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-10-23 |
4 |
AS |
$5.08 |
$30,460 |
D/D |
(6,000) |
129,724 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-08-21 |
4 |
AS |
$7.32 |
$43,895 |
D/D |
(6,000) |
135,724 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-06-20 |
4 |
AS |
$10.28 |
$61,663 |
D/D |
(6,000) |
141,724 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-03 |
4 |
S |
$12.63 |
$202,615 |
D/D |
(16,037) |
147,724 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
163,761 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
S |
$12.37 |
$183,024 |
D/D |
(14,800) |
151,261 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
74,675 |
166,061 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
AS |
$13.06 |
$65,311 |
D/D |
(5,000) |
91,386 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-12-15 |
4 |
AS |
$15.88 |
$79,412 |
D/D |
(5,000) |
96,386 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-10-17 |
4 |
AS |
$15.98 |
$79,908 |
D/D |
(5,000) |
101,386 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-04-18 |
4 |
AS |
$16.28 |
$488,298 |
D/D |
(30,000) |
106,386 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-03-10 |
4 |
S |
$15.71 |
$426,803 |
D/D |
(27,165) |
136,386 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
163,551 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,750 |
151,051 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
S |
$12.68 |
$4,857 |
D/D |
(383) |
87,301 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,050 |
87,684 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2021-09-01 |
4 |
D |
$17.22 |
$17,926 |
D/D |
(1,041) |
86,634 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2021-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,333 |
87,675 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2021-06-02 |
4 |
S |
$21.50 |
$471,437 |
D/D |
(21,790) |
85,342 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
